nrsg351 respiratory agents in asthma, copd, cough, cold and allergy

37
Civility Clause…. Students are expected to behave toward lecturers and fellow students with courtesy and consideration. This means that talking and disruptive behavior will be kept to a minimum. Cell phones, pagers, and other electronic devices should be silenced in the classroom. I reserve the right to end a class at any time, for any reason, including the disruptive or rude

Upload: ann-massey

Post on 07-May-2015

195 views

Category:

Healthcare


2 download

DESCRIPTION

powerpoint presentation for nursing students, Nell Hodgson Woodruff School of Nursing, Emory University, spring 2014

TRANSCRIPT

Page 1: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

Civility Clause….

Students are expected to behave toward lecturers and fellow students with courtesy and consideration. This means that talking and disruptive behavior will be kept to a minimum. Cell phones, pagers, and other electronic devices should be silenced in the classroom. I reserve the right to end a class at any time, for any reason, including the disruptive or rude behavior of anyone in the classroom.

Page 2: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy
Page 3: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy
Page 4: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

Trigger Mechanism

Respiratory infection Inflammatory response produces bronchial hyperresponsiveness; IgE induction by some viruses; eosinophil activation by some viruses

Allergens Classic allergic pathway

Environment / occupational stimuli

Epithelial damage; inflammation

Emotions Excess parasympathetic activation of bronchial tissue

Exercise Heat loss and water loss from airways;

Drugs , foods Sulfite preservatives stimulate inflammation; aspirin and NSAIDS inhibit cyclooxygenase

Page 5: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

http://www.nhlbi.nih.gov/health/health-topics/topics/asthma/

Page 6: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

http://nursingcrib.com/wp-content/

Page 7: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

Asthma COPD

Early onset; family history Mid-life onset

Variable or seasonal symptoms; symptoms worse at night or early morning

Slowly progressing symptoms

Associated with allergies / rhinitis; eczema; dermatitis

History of smoking

REVERSIBLE airway obstruction IRREVERSIBLE (or variably reversible) airway obstruction

Page 8: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy
Page 9: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

Goals of therapy in acute asthma

• Rapid reversal of airway obstruction

• Correction of significant hypoxemia

• Restoration of normal lung function

• Reduction of asthma symptoms

• Development of a plan for future attacks

Page 10: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

http://www.uptodate.com/patients/content/image.do?imageKey=PULM%2F23550

Page 11: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

http://www.uptodateonline.com/patients/content/image.do?imageKey=PULM%2F22761

Page 12: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

Drugs used to treat asthma

• Bronchodilators– Beta 2 agonists– Anticholinergics

• Antiinflammatory agents– Corticosteroids– Leukotriene modifiers– Mast cell stabilizers– Monoclonal antibodies

Agents can be used systemically or via inhalation

Page 13: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

Beta-2 agonistsAlbuterol (Ventolin® Proventil® Accuneb® )Levalbuterol (Xopenex®)

Fluticasone / salmeterol (Advair®)Mometasone furoate / formoterol fumarate (Dulera®)

Formoterol fumarate (Foradil®)

Pharmacology (Mechanism of action)

Stimulates b-2 receptors

Activates adenylate cyclase and increases cAMP

cAMP produces relaxation of smooth muscle and bronchodilation

Adverse Effects Pharmacokinetics

Short-acting

Long-acting

Page 14: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

Beta-2 agonists

• Contraindications

– Allergy

– Uncontrolled cardiac dysrhythmias (especially tachyarrhythmias)

Page 15: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

Beta-2 agonists

• Adverse effects – serious– Urticaria

– Arrhythmia, QT prolongation, angina, hypokalemia

– Paradoxical bronchospasm

• Adverse effects – common– Nervousness, tremor, palpitations, tachycardia

– Bad taste

– Throat irritation

Page 16: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

MethylxanthinesTheophylline (Theo-Dur®)Aminophylline (various)

Pharmacology (Mechanism of action)

Block phosphodiesterase enzymes, which leads to increased cAMP in bronchial tissue

Increased cAMP leads to smooth muscle relaxation

Adverse Effects Pharmacokinetics

Page 17: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

Anticholinergics Ipratropium bromide (Atrovent®)Tiotropium bromide (Spiriva Handihaler®)

Pharmacology (Mechanism of action)

Blocks post ganglionic vagal pathways

Decreased vagal tone produces bronchodilation

Adverse Effects Pharmacokinetics

Page 18: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

N3HCCH

CH3

CH3

O C

O

CH

OH

Br-

Ipratropium bromide

Page 19: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

Anticholinergics

• Contraindicated in– Allergy to atropine or components of the

preparation

– Myasthenia gravis, narrow angle glaucoma

– Tiotropium should not be used with ipratropium

• Adverse effects – common– Nausea, vomiting, diarrhea

– Nasal congestion, dyspnea

Page 20: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

Corticosteroids Beclomethasone (Beclovent® Vanceril® QVAR80® )Budesonide (Pulmicort®)

Fluticasone / salmeterol (Advair®)

Triamcinolone acetonide (Azmacort®)

Pharmacology (Mechanism of action)

Inhibits neutrophil and eosinophil invasion

Inhibits synthesis of prostaglandins, histamines and leukotrienes

Adverse Effects Pharmacokinetics

http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm213836.htm

Page 21: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

Corticosteroids

• Adverse effects – serious (most are rare when inhaled)– Adrenal suppression– Osteoporosis / growth suppression in children– Bronchospasm– Peptic ulcers

• Adverse effects – common – Sinusitis, rhinitis, hoarseness– Headache, nausea, diarrhea– Oral candidiasis

Page 22: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

Leukotriene receptor antagonistsMontelukast (Singulair®)Zileuton (Zyflo®)Zafirlukast (Accolate®)Pharmacology (Mechanism of action)

blocks leukotriene receptors

Prevents leukotrienes from participating in inflammatory responses

Adverse Effects Pharmacokinetics

Page 23: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

Arachidonic acid

Lipoxygenase products

lipoxygenase

LTC4 and LTD4

TXA2COX

Bronchoconstrictionand inflammation

Montelukast, zafirlukast(receptor antagonists) act here

Zileuton act here

Page 24: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

Leukotriene modifiers

• Adverse effects – serious– Angioedema– Anaphylaxis – Churg-Strauss syndrome (coincidental?)

• Adverse effects – common– Flu like symptoms (cough, fatigue, headache,

abdominal pain)

– Adverse effects have not been well documented and these agents are believed to be very safe

Page 25: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

Mast Cell StabilizersCromolyn sodium (Nasalcrom® , Intal®)

Pharmacology (Mechanism of action)

Prevent the release of histamine and inflammatory mediators by mast cells by stabilizing their membranes;

Reduced release of inflammatory and bronchoconstrictive substances reduces bronchoconstriction

Adverse Effects Pharmacokinetics

Page 26: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

Monoclonal antibody preparationsOmalizumab (Xolair®)

Pharmacology (Mechanism of action)

inhibits IgE binding to receptors on mast cells and basophils, preventing degranulation

Reduces release of allergic response mediators

Adverse Effects Pharmacokinetics

Page 27: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

Upper Respiratory Medications

• Antihistamines, decongestants and other nasal agents

• Common, available OTC and Rx

• Alone and in combination

• Use in children is discouraged

Page 28: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

Antihistamines1st generation OTC 2nd generation OTCDimenhydrinate (Dramamine ®) Cetirizine (Zyrtec ®)Diphenhydramine HCl (Benadryl®) loratidine (Claritin®, Chlorpheniramine (Chlor-Trimeton®) des-loratidine (Clarinex®) fexofenadine (Allegra®, Allegra-D®) Pharmacology (Mechanism of action)

Blocks H1 receptors

Histamine cannot bind, produce responses associated with allergic responses

(No effect to decrease histamine release)

Adverse Effects Pharmacokinetics

Page 29: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

DecongestantsTopical (intranasal) OTC Systemic OTCOxymetazoline (Afrin®, Allerest®) Pseudoephedrine (Sudafed®)Phenylephrine (Neo-synephrine®)Xylometazoline (Otrivin ®)

Pharmacology (Mechanism of action)

a1 stimulation produces vasoconstriction

Vasoconstriction leads to decreased swelling, edema and stuffy nasal passages

Adverse Effects Pharmacokinetics

Page 30: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

Decongestants

• Contraindicated in patients with – Hypertension or CAD– Do not use concurrently with TCAs, beta

blockers, MAOIs

• Adverse effects include– Tachycardia, increased BP, arrhythmias– Restlessness, insomnia, anxiety, tremor– Rebound phenomenon

Page 31: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

Intranasal antiinflammatory agentsCorticosteroids - RxTriamcinolone acetonide (Nasacort ®) Budesonide (Rhinocort®) Fluticasone (Flonase®) Pharmacology (Mechanism of action)

Decreases the release of inflammatory mediators

Adverse Effects Pharmacokinetics

Page 32: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

Agents used to treat cough

• Antitussives – prevent coughing

• Expectorants – thin mucus secretions, making it easier to cough

Page 33: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

ExpectorantsGuaifenesin (Robitussin, Mucinex) Pharmacology (Mechanism of action)

Decreases the viscosity of mucus to aid in its elimination

Adverse Effects Pharmacokinetics

Page 34: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

AntitussivesDextromethorphan (Robitussin-DM, Mucinex-DM, Delsym) Pharmacology (Mechanism of action)

Depresses medullary cough center

Adverse Effects Pharmacokinetics

Page 35: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

dextromethorphan

Levophoranol (Levo-Dromoran)

Page 36: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

Antitussives – Rx codeine containing and derivatives(Tussionex, Tussi-organidin) Pharmacology (Mechanism of action)

Depresses medullary cough center

Adverse Effects Pharmacokinetics

Page 37: NRSG351 Respiratory Agents in Asthma, COPD, Cough, Cold and Allergy

Antitussives – RxNon-codeine derivatives

Benzonatate (Tessalon Perles) Pharmacology (Mechanism of action)

Local anesthetic action on the respiratory passageways and stretch receptors of the lung; decreases cough reflex

Adverse Effects Pharmacokinetics